Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Panitumumab in Advanced Renal Cell Carcinoma
NCT00425035Phase 2Completed
- Sponsor
- Amgen
- Start
- Feb 2003
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
01
Overview
A Phase 2 trial of panitumumab in renal cell carcinoma (RCC), sponsored by Amgen. Started Feb 2003; status: completed.
02
Drugs
panitumumab
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00425035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00425035.